Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

G17DT increases median survival time of patients with advanced pancreatic cancer

Oct. 31, 2002

Promising safety results reported for CpG-7909 as adjuvant to antitumor vaccination

Oct. 31, 2002

Phase III Provenge trial resumes enrollment

Oct. 30, 2002

Interim results from phase II gastric cancer trial of pemtumomab presented

Oct. 25, 2002

Subcutaneous alemtuzumab reported to be safe and effective for B-CLL

Oct. 23, 2002

Cell Genesys reacquires full commercial rights to GVAX lung cancer vaccines

Oct. 22, 2002

Phase II Multikine trial in head and neck cancer completes enrollment

Oct. 21, 2002

EGFR-targeted MAb improves response to radiotherapy in SCCHN

Oct. 18, 2002

PrimeBoost melanoma pharmaccine advances to phase II testing

Oct. 16, 2002

Phase I trial initiated for HER-2 vaccine for breast cancer

Oct. 16, 2002

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026